• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV-1附着抑制剂。第2部分:吲哚取代模式的初步研究。

Inhibitors of HIV-1 attachment. Part 2: An initial survey of indole substitution patterns.

作者信息

Meanwell Nicholas A, Wallace Owen B, Fang Haiquan, Wang Henry, Deshpande Milind, Wang Tao, Yin Zhiwei, Zhang Zhongxing, Pearce Bradley C, James Jennifer, Yeung Kap-Sun, Qiu Zhilei, Kim Wright J J, Yang Zheng, Zadjura Lisa, Tweedie Donald L, Yeola Suresh, Zhao Fang, Ranadive Sunanda, Robinson Brett A, Gong Yi-Fei, Wang Hwei-Gene Heidi, Spicer Timothy P, Blair Wade S, Shi Pei-Yong, Colonno Richard J, Lin Pin-Fang

机构信息

Department of Chemistry, Bristol-Myers Squibb Research and Development, 5 Research Parkway, Wallingford, CT 06492, United States.

出版信息

Bioorg Med Chem Lett. 2009 Apr 1;19(7):1977-81. doi: 10.1016/j.bmcl.2009.02.040. Epub 2009 Feb 13.

DOI:10.1016/j.bmcl.2009.02.040
PMID:19251416
Abstract

The effects of introducing simple halogen, alkyl, and alkoxy substituents to the 4, 5, 6 and 7 positions of 1-(4-benzoylpiperazin-1-yl)-2-(1H-indol-3-yl)ethane-1,2-dione, an inhibitor of the interaction between HIV gp120 and host cell CD4 receptors, on activity in an HIV entry assay was examined. Small substituents at C-4 generally resulted in increased potency whilst substitution at C-7 was readily tolerated and uniformly produced more potent HIV entry inhibitors. Substituents deployed at C-6 and, particularly, C-5 generally produced a modest to marked weakening of potency compared to the prototype. Small alkyl substituents at N-1 exerted minimal effect on activity whilst increasing the size of the alkyl moiety led to progressively reduced inhibitory properties. These studies establish a basic understanding of the indole element of the HIV attachment inhibitor pharmacophore.

摘要

1-(4-苯甲酰基哌嗪-1-基)-2-(1H-吲哚-3-基)乙烷-1,2-二酮是一种HIV gp120与宿主细胞CD4受体相互作用的抑制剂,研究了在其4、5、6和7位引入简单卤素、烷基和烷氧基取代基对HIV进入试验活性的影响。C-4位的小取代基通常会导致活性增加,而C-7位的取代很容易被耐受,并且一致地产生更有效的HIV进入抑制剂。与原型相比,C-6位尤其是C-5位的取代基通常会使活性适度至显著减弱。N-1位的小烷基取代基对活性影响最小,而增加烷基部分的大小会导致抑制特性逐渐降低。这些研究建立了对HIV附着抑制剂药效团中吲哚元素的基本认识。

相似文献

1
Inhibitors of HIV-1 attachment. Part 2: An initial survey of indole substitution patterns.HIV-1附着抑制剂。第2部分:吲哚取代模式的初步研究。
Bioorg Med Chem Lett. 2009 Apr 1;19(7):1977-81. doi: 10.1016/j.bmcl.2009.02.040. Epub 2009 Feb 13.
2
Inhibitors of HIV-1 attachment. Part 3: A preliminary survey of the effect of structural variation of the benzamide moiety on antiviral activity.HIV-1附着抑制剂。第3部分:苯甲酰胺部分结构变异对抗病毒活性影响的初步研究。
Bioorg Med Chem Lett. 2009 Sep 1;19(17):5136-9. doi: 10.1016/j.bmcl.2009.07.027. Epub 2009 Jul 10.
3
Inhibitors of HIV-1 attachment. Part 4: A study of the effect of piperazine substitution patterns on antiviral potency in the context of indole-based derivatives.HIV-1附着抑制剂。第4部分:在吲哚类衍生物背景下哌嗪取代模式对抗病毒效力影响的研究。
Bioorg Med Chem Lett. 2009 Sep 1;19(17):5140-5. doi: 10.1016/j.bmcl.2009.07.076. Epub 2009 Jul 18.
4
Inhibitors of human immunodeficiency virus type 1 (HIV-1) attachment. 5. An evolution from indole to azaindoles leading to the discovery of 1-(4-benzoylpiperazin-1-yl)-2-(4,7-dimethoxy-1H-pyrrolo[2,3-c]pyridin-3-yl)ethane-1,2-dione (BMS-488043), a drug candidate that demonstrates antiviral activity in HIV-1-infected subjects.1型人类免疫缺陷病毒(HIV-1)附着抑制剂。5. 从吲哚到氮杂吲哚的演变,从而发现了1-(4-苯甲酰基哌嗪-1-基)-2-(4,7-二甲氧基-1H-吡咯并[2,3-c]吡啶-3-基)乙烷-1,2-二酮(BMS-488043),一种在HIV-1感染受试者中显示出抗病毒活性的候选药物。
J Med Chem. 2009 Dec 10;52(23):7778-87. doi: 10.1021/jm900843g.
5
Inhibitors of human immunodeficiency virus type 1 (HIV-1) attachment. 12. Structure-activity relationships associated with 4-fluoro-6-azaindole derivatives leading to the identification of 1-(4-benzoylpiperazin-1-yl)-2-(4-fluoro-7-[1,2,3]triazol-1-yl-1h-pyrrolo[2,3-c]pyridin-3-yl)ethane-1,2-dione (BMS-585248).人免疫缺陷病毒 1 型(HIV-1)附着抑制剂。12. 与导致鉴定 1-(4-苯甲酰哌嗪-1-基)-2-(4-氟-7-[1,2,3]三唑-1-基-1H-吡咯并[2,3-c]吡啶-3-基)乙烷-1,2-二酮 (BMS-585248) 的 4-氟-6-氮杂吲哚衍生物相关的结构-活性关系。
J Med Chem. 2013 Feb 28;56(4):1656-69. doi: 10.1021/jm3016377. Epub 2013 Feb 7.
6
Discovery of 4-benzoyl-1-[(4-methoxy-1H- pyrrolo[2,3-b]pyridin-3-yl)oxoacetyl]-2- (R)-methylpiperazine (BMS-378806): a novel HIV-1 attachment inhibitor that interferes with CD4-gp120 interactions.4-苯甲酰基-1-[(4-甲氧基-1H-吡咯并[2,3-b]吡啶-3-基)氧代乙酰基]-2-(R)-甲基哌嗪(BMS-378806)的发现:一种新型的HIV-1附着抑制剂,可干扰CD4与gp120的相互作用。
J Med Chem. 2003 Sep 25;46(20):4236-9. doi: 10.1021/jm034082o.
7
Inhibitors of HIV-1 attachment: The discovery and structure-activity relationships of tetrahydroisoquinolines as replacements for the piperazine benzamide in the 3-glyoxylyl 6-azaindole pharmacophore.HIV-1附着抑制剂:四氢异喹啉作为3-乙醛基-6-氮杂吲哚药效团中哌嗪苯甲酰胺替代物的发现及其构效关系。
Bioorg Med Chem Lett. 2016 Jan 1;26(1):160-7. doi: 10.1016/j.bmcl.2015.11.009. Epub 2015 Nov 5.
8
Discovery of a small molecule inhibitor through interference with the gp120-CD4 interaction.通过干扰gp120与CD4的相互作用发现一种小分子抑制剂。
Bioorg Med Chem Lett. 2009 Sep 1;19(17):5246-9. doi: 10.1016/j.bmcl.2009.06.080. Epub 2009 Jun 25.
9
Design and optimisation of potent gp120-CD4 inhibitors.强效gp120-CD4抑制剂的设计与优化。
Bioorg Med Chem Lett. 2009 Sep 1;19(17):5250-5. doi: 10.1016/j.bmcl.2009.06.102. Epub 2009 Jul 4.
10
CD4 mimics targeting the mechanism of HIV entry.CD4 模拟物针对 HIV 进入机制。
Bioorg Med Chem Lett. 2010 Jan 1;20(1):354-8. doi: 10.1016/j.bmcl.2009.10.098. Epub 2009 Nov 4.

引用本文的文献

1
Recent progress in therapeutic applications of fluorinated five-membered heterocycles and their benzo-fused systems.含氟五元杂环及其苯并稠合体系在治疗应用中的最新进展。
RSC Adv. 2024 Oct 25;14(46):33864-33905. doi: 10.1039/d4ra05697c. eCollection 2024 Oct 23.
2
Indol-3-ylglyoxylamide as Privileged Scaffold in Medicinal Chemistry.吲哚-3-乙醛酰胺作为药物化学中的优势骨架。
Pharmaceuticals (Basel). 2023 Jul 12;16(7):997. doi: 10.3390/ph16070997.
3
Innovation in the discovery of the HIV-1 attachment inhibitor temsavir and its phosphonooxymethyl prodrug fostemsavir.
HIV-1附着抑制剂替沙韦及其膦酰氧基甲基前药福沙韦的发现中的创新。
Med Chem Res. 2021;30(11):1955-1980. doi: 10.1007/s00044-021-02787-6. Epub 2021 Sep 28.
4
The Alpha Keto Amide Moiety as a Privileged Motif in Medicinal Chemistry: Current Insights and Emerging Opportunities.α-酮酰胺部分作为药物化学中的一个优势结构:当前的见解和新兴机遇。
J Med Chem. 2021 Apr 8;64(7):3508-3545. doi: 10.1021/acs.jmedchem.0c01808. Epub 2021 Mar 25.
5
Computational design, synthesis and evaluation of new sulphonamide derivatives targeting HIV-1 gp120.针对 HIV-1 gp120 的新型磺胺衍生物的计算设计、合成与评估。
J Comput Aided Mol Des. 2020 Jan;34(1):39-54. doi: 10.1007/s10822-019-00258-0. Epub 2019 Dec 2.
6
Field-Based Affinity Optimization of a Novel Azabicyclohexane Scaffold HIV-1 Entry Inhibitor.基于现场的新型氮杂环己烷 HIV-1 进入抑制剂的亲和力优化。
Molecules. 2019 Apr 22;24(8):1581. doi: 10.3390/molecules24081581.
7
Lattice engineering enables definition of molecular features allowing for potent small-molecule inhibition of HIV-1 entry.晶格工程使定义分子特征成为可能,从而能够有效地抑制 HIV-1 的进入。
Nat Commun. 2019 Jan 3;10(1):47. doi: 10.1038/s41467-018-07851-1.
8
Homology models of the HIV-1 attachment inhibitor BMS-626529 bound to gp120 suggest a unique mechanism of action.与gp120结合的HIV-1附着抑制剂BMS-626529的同源模型表明了一种独特的作用机制。
Proteins. 2015 Feb;83(2):331-50. doi: 10.1002/prot.24726. Epub 2014 Dec 23.
9
Illuminating HIV gp120-Ligand Recognition through Computationally-Driven Optimization of Antibody-Recruiting Molecules.通过计算驱动的抗体招募分子优化阐明HIV gp120-配体识别
Chem Sci. 2014 Jun 1;5(6):2311-2317. doi: 10.1039/C4SC00484A.
10
Chemically Programmed Antibodies AS HIV-1 Attachment Inhibitors.化学编程抗体作为HIV-1附着抑制剂
ACS Med Chem Lett. 2013 May 9;4(5):460-465. doi: 10.1021/ml400097z.